12
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Evaluation of features of syndrome X in offspring of Caribbean patients with Type 2 diabetes

Pages 19-26 | Published online: 08 Jul 2009

REFERENCES

  • Olefsky JM, Kolterman OG, Scarlett JA. Insulin action and resistance in obesity and NIDDM. Am J Physiol 1982; 243: EIS —E30.
  • DeFronzo RA, Simmonson D, Ferrannini E. Hepatic and perihperal insulin resistance: a common feature of type 2 (non-insulin dependent) and type 1 (insulin dependent) diabetes mellitus. Diabetologia 1982; 23: 313— 19.
  • Weir GC. Non-insulin dependent diabetes melli-tus: interplay between B-cell inadequacy and insulin resistance. Am J Med 1982; 73: 461–4.
  • Reaven GM. Insulin resistance in NIDDM. Does it exist and can it be measured? Am J Med 1983; 74: 3–17.
  • Barnett AH, Effo C, Leslie RD, Pyke DA. Diabetes in identical twins: a study of 200 pairs. Diabetologia 1981; 20: 87–93.
  • Newman B, Sleby JV, King MC, Slemenda C, Fabsitz P, Friedman CD. Concordance for type 2 (NIDDM) diabetes in male twins. Diabetologia 1987; 30: 763–8.
  • Osei K, Cottrell DA, Adejuwon CA, Ezenwaka CE, Akanji AO, O'Doriso TM. Serum insulin and glucose concentrations in people at risk for type II diabetes: a comparative study of African Amer-icans and Nigerians. Diabetes Care 1993; 16(10): 1367 — 75.
  • Ezenwaka CE, Akanji AO, Osei K, Adejuwon CA, O'Dorisio TM, Cotrell DA, Akinlade KS. Glucose and insulin responses to intravenous glucose challenge in relatives of Nigerian patients with non-insulin dependent diabetes mellitus. Diabetes Res Clin Pract 1993; 20: 175–81.
  • Eriksson JE, Franssila KA, Ekstrand CS, Widen W, Schalin C. Early metabolic defects in persons at increased risk for non-insulin dependent diabetes mellitus. N Engl J Med 1989; 320: 337–43.
  • Warram JH, Blaise CM, Andrzej S, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinaemia precede the development of type II diabetes in the offsprings of diabetic parents. Ann hit Med 1990; 113: 909–15.
  • Osei K. Increased basal glucose production and utilisation in non-diabetic first-degree relatives of patients with NIDDM. Diabetes 1990; 39: 597— 601.
  • Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK. Increased insulin concentration in non-diabetic offsprings of diabetic parents. N Engl J Med 1988; 319: 1297–301.
  • Van Haeften TW, Dubbeldam S, Zonderland ML, Erkelens DW. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects: Assessments using hyperglycemic glucose clamp and oral glucose tolerance tests. Diabetes Care 1998; 21(2): 278–82.
  • Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V. Study of genetic prediabetic South Indian subjects: importance of hyperinsulinemia and B-cell dysfunction. Diabetes Care 1998; 21(1): 76–9.
  • Reaven GM. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–607.
  • DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidaemia and athero-sclerotic vascular disease. Diabetes Care 1991; 18: 173–94.
  • Zavaroni I, Bonini L, Fantuzzi M, Dall'Aglio E, Passeri M, Reaven GM. Hyperinsulinaemia, obesity and syndrome X. J Int Med 1994; 235: 51–6.
  • Gaillard TR, Schuster DP, Bossetti BM, Green PA, Osei K. The impact of socioeconomic status on cardiovascular risk factors in African-Amer-icans at high risk for type II diabetes: implications for syndrome X. Diabetes Care 1997; 20(5): 745–52.
  • Stewart MW, Humphriss DB, Berrish TS, Barriocanal LA, Trajano LR, Alberti KG, Walker M. Features of syndrome X in first-degree relatives of NIDDM patients. Diabetes Care 1995; 18(7): 1020–2.
  • Republic of Trinidad, and Tobago, Central Statis-tical Office, Population and Housing Census. Vol. II: Age, structure, religion, ethnic group, educa-tion. Port of Spain Central Statistical Office, 1994.
  • Miller GJ, Maude GH, Beckles GLA. Incidence of hypertension and non-insulin dependent diabetes mellitus and associated risk factors in a rapidly developing Caribbean community: the St James survey, Trinidad. J Epidemiological Community Health 1996; 50: 497–504.
  • Gulliford MC. Epidemiological transition in Trinidad and Tobago, West Indies 1953-1992. Inter J Epidemiol 1996; 25: 357–65.
  • Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Medicine 1997; 14\(Suppl 5): S7—S85.
  • Turner RC, Holman RR, Matthews D, Hockaday TDR, Peto J. Insulin deficiency and insulin resistance interaction in diabetes: estimation of their relative contribution by feedback analysis from basal plasma insulin and glucose concentra-tions. Metabolism 1979; 28: 1086–96.
  • Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homesotasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concen-trations in man. Diabetologia 1985; 28: 412–19.
  • Hypertension Detection and Follow-up Pro-gramme Cooperative Group. Blood pressure studies in 14 communities: a two stage screen for hypertension. JAMA 1977; 237: 2385–91.
  • Friedwald WT, Levy RI, Fredrickson DS. Estima-tion of the concentration of low-density lipopro-tein in plasma without use of preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
  • Statistical Package for the Social Sciences (SPSS) for Windows. User's Guide. New York: McGraw-Hill, 1999.
  • World Health Organization Expert Committee. Arterial hypertension. WHO Technical Report Series No 628, 1978.
  • DECODE Study Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. Lancet 1999; 354: 617–21.
  • World Health Organization Working Group. Use and interpretation of anthropometric indicators of nutritional status. Bull WHO 1986; 64: 929–41.
  • Zimmet P, Collins VR, Dowse GR, et al. The relation of physical activity to cardiovascular risk factors in Mauritians. Am J Epidemiol 1991; 134: 862— 75.
  • National Cholesterol Education Program Expert Panel. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 1993; 269: 3015—23.
  • Reaven GM, Lerner RL, Stern MP, Farquhar JW. Role of insulin in endogenous hypertriglyceride-mia. J Clin Invest 1967; 46: 1756–67.
  • Olefsky JM, Farquhar JW, Reave GM. Reapprai-sal of the role of insulin in hypertriglyceridemia. Am J Med 1974; 57: 551–60.
  • Tobey TA, Greenfield M, Kraemer F, Reaven GM. Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics and plasma triglyceride levels in normotriglyceri-demic man. Metabolism 1981; 30: 165–71.
  • Zavaroni I, Dall'Aglio E, Alpi 0, Bruschi E, Bonora E, Pezzarossa A, Butturini V. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis 1985; 55: 259–66.
  • Haffner SM, Fong D, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia, upper body adiposity and cardiovascular risk factors in non diabetes. Metabolism 1988; 37: 338–45.
  • Stern MP, Haffner SM. Body fat distribtution and hyperinsulinaemia as risk factors for diabetes and cardiovascular disease. Atherosclerosis 1986; 6: 123— 30.
  • Cullen K, Stenhouse NS, Wearne KL, Welborne TA. Multiple regression analysis of risk factors for cardiovascular disease and cancer mortality in Busselton, Western Australia: 13 year study. J Chronic Disease 1983; 36: 371–7.
  • Ishikawa M, Pruneda ML, Adams-Huet B, Raskin P. Obesity-independent hyperinsulinaemia in non-diabetic first-degree relatives of individuals with type 2 diabetes. Diabetes 1998; 47(5): 788–892.
  • Nyholm B, Mengel A, Nielsen S, Skjaerbaek CB, Moller N, Alberti KG, Schmitz OE. Insulin resistance among relatives of patients with NIDDM. Significance of physical fitness and muscle metabolism. Ugestkrift Laeger 1998; 164(4): 410–15.
  • Henkin L, Zaccaro D, Haffner S, Karter A, Rewers M, Sholin sky P, Wagenknecht L. Cigarette smoking, environmental tobacco smoke exposure and insulin sensitivity: the Insulin Resistance Atherosclerosis Study. Ann Epidemiol 1999; 9(5): 290–6.
  • Ronnemaa EM, Ronnemaa T, Utriainen T, Raitakari M, LaMe H, Takala T, Pitkanen OP, Kirvela 0, Knuuti J, Nuutila P. Decreased blood flow but unaltered insulin sensitivity of glucose uptake in skeletal muscle of chronic smokers. Metabolism 1999; 48(2): 239–44.
  • Targher G, Alberiche M, Zenere MB, Bonadonna RC, Muggeo M, Bonora E. Cigarette smoking and insulin resistance in patients with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1997; 82(11): 3619–24.
  • Eliasson B, Mero N, Taskinen MR, Smith U. The insulin resistance syndrome and postprandial lipid intolerance in smokers. Atherosclerosis 1997; 129(1): 79–88.
  • Frati AC, Iniestra F, Ariza CR. Acute effect of cigarette smoking on glucose tolerance and other cardiovascular risk factors. Diabetes Care 1996; 19(2): 112–18.
  • Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: Studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000; 23: 57–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.